PT  - JOURNAL ARTICLE
AU  - Alice B. Gottlieb
AU  - April W. Armstrong
TI  - Psoriasis Outcome Measures: A Report from the GRAPPA 2012 Annual Meeting
AID  - 10.3899/jrheum.130456
DP  - 2013 Aug 01
TA  - The Journal of Rheumatology
PG  - 1428--1433
VI  - 40
IP  - 8
4099  - http://www.jrheum.org/content/40/8/1428.short
4100  - http://www.jrheum.org/content/40/8/1428.full
SO  - J Rheumatol2013 Aug 01; 40
AB  - Psoriasis is a multisystem disease. The cutaneous and musculoskeletal manifestations (psoriatic arthritis) are well recognized. However, the other manifestations of psoriatic disease including metabolic syndrome, atherosclerotic cardiovascular disease, depression, poor self-esteem, and self-destructive habits including obesity, smoking and excess alcohol consumption are underappreciated. At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), members addressed the need to develop uniform, validated, standardized outcome measures for psoriatic disease, measures that are useful to all stakeholders including patients, physicians, regulators, and payers.